MPA: A treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis [PDF]
Jan Halbritter +5 more
openalex +1 more source
Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study. [PDF]
AlRasheed HA +5 more
europepmc +1 more source
FORMULATION DEVELOPMENT OF COLON TARGETED MESALAMINE PELLETS: IN VITRO-IN VIVO RELEASE STUDY
Jagan Bahekar, S. J. Wadher
openalex +2 more sources
Crohn's disease-like perianastomotic ulcerations after neonatal necrotizing enterocolitis surgery: a case of successful anti-TNF therapy. [PDF]
Lina S, Xinyi W, Xiaoxia R, Yanan H.
europepmc +1 more source
Expression of concern: Recyclable mesalamine-functionalized magnetic nanoparticles (mesalamine/GPTMS@SiO<sub>2</sub>@Fe<sub>3</sub>O<sub>4</sub>) for tandem Knoevenagel-Michael cyclocondensation: grinding technique for the synthesis of biologically active 2-amino-4<i>H</i>-benzo[<i>b</i>]pyran derivatives. [PDF]
Partovi M +4 more
europepmc +1 more source
Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD? [PDF]
Ekbom, Anders +2 more
core +1 more source
The adjunctive role of metformin in patients with mild to moderate ulcerative colitis: a randomized controlled study. [PDF]
Binsaleh AY +9 more
europepmc +1 more source
A case of bullous pemphigoid in an ulcerative colitis patient treated with vedolizumab. [PDF]
Odom MB +3 more
europepmc +1 more source

